For procurement professionals in the pharmaceutical industry, securing high-quality raw materials is a top priority. When it comes to the synthesis of Eplerenone, a vital medication for managing hypertension and heart conditions, the intermediate 11α-Hydroxy Canrenone (CAS 192569-17-8) is indispensable. NINGBO INNO PHARMCHEM CO.,LTD. offers insights into sourcing this critical compound effectively.

The primary consideration when sourcing 11α-Hydroxy Canrenone is its purity. Pharmaceutical applications demand intermediates with minimal impurities and consistent assay levels, often requiring a purity of 98.0% or higher. Buyers should look for suppliers who provide detailed Certificates of Analysis (COA) and adhere to stringent quality control measures. Understanding the physical properties, such as its appearance as a yellow crystalline powder, is also important for quality verification.

When evaluating suppliers, consider their manufacturing capabilities, R&D strength, and adherence to international quality standards like ISO certifications. NINGBO INNO PHARMCHEM CO.,LTD. operates with a commitment to these principles, ensuring that our pharmaceutical intermediates are produced under controlled conditions. We offer transparent communication regarding product specifications, packaging, and delivery timelines.

The market for Eplerenone, and consequently for its key intermediate 11α-Hydroxy Canrenone, is influenced by the growing global prevalence of cardiovascular diseases. This trend underscores the importance of establishing reliable supply partnerships. By choosing NINGBO INNO PHARMCHEM CO.,LTD., you are partnering with a company that understands the pharmaceutical supply chain and is dedicated to meeting your needs for high-quality 11α-Hydroxy Canrenone. Our team is ready to assist you with your purchase, offering competitive pricing and efficient logistics.